Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$718M |
| 2 |
Microsoft
MSFT
|
+$662M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$404M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$342M |
| 5 |
NVIDIA
NVDA
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$713M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$711M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$709M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$626M |
| 5 |
Home Depot
HD
|
+$561M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.54% |
| 2 | Healthcare | 5.02% |
| 3 | Consumer Discretionary | 4.7% |
| 4 | Financials | 4.22% |
| 5 | Communication Services | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADAP
3226
DELISTED
Adaptimmune Therapeutics
ADAP
| $539K | ﹤0.01% |
582,196
+580,541
| +35,078% | +$692K |
|
3227
Invesco Bond Fund
VBF
$167M
| $536K | ﹤0.01% |
36,002
+32,774
| +1,015% | +$500K |
|
|
DOO
3228
Bombardier Recreational Products
DOO
$4.48B
| $536K | ﹤0.01% |
6,328
+1,717
| +37% | +$130K |
|
3229
iShares Core S&P US Growth ETF
IUSG
$30.4B
| $534K | ﹤0.01% |
5,473
-661
| -11% | -$60.6K |
|
3230
Kelly Services Class A
KELYA
$548M
| $534K | ﹤0.01% |
30,312
+7,802
| +35% | +$135K |
|
3231
Invesco Mortgage Capital
IVR
$759M
| $533K | ﹤0.01% |
46,432
+6,068
| +15% | +$64.9K |
|
|
CBAY
3232
DELISTED
Cymabay Therapeutics
CBAY
| $532K | ﹤0.01% |
48,597
-185,699
| -79% | -$1.73M |
|
|
JPUS
3233
JPMorgan Diversified Return US Equity ETF
JPUS
$459M
| $529K | ﹤0.01% |
5,414
+2,161
| +66% | +$205K |
|
3234
WisdomTree International SmallCap Dividend Fund
DLS
$1.04B
| $528K | ﹤0.01% |
8,888
+62
| +0.7% | +$3.78K |
|
3235
Pilgrim's Pride
PPC
$7.13B
| $528K | ﹤0.01% |
24,590
-7,641
| -24% | -$172K |
|
3236
Procore
PCOR
$7.57B
| $528K | ﹤0.01% |
8,114
+5,561
| +218% | +$327K |
|
|
PFC
3237
DELISTED
Premier Financial Corp. Common Stock
PFC
| $527K | ﹤0.01% |
32,894
+22,082
| +204% | +$363K |
|
|
SNBR
3238
DELISTED
Sleep Number
SNBR
| $525K | ﹤0.01% |
19,252
+5,812
| +43% | +$133K |
|
3239
Horizon Bancorp
HBNC
$1.06B
| $524K | ﹤0.01% |
50,374
+48,032
| +2,051% | +$477K |
|
3240
Enact Holdings
ACT
$6.75B
| $523K | ﹤0.01% |
20,829
+13,328
| +178% | +$325K |
|
|
NNDM
3241
Nano Dimension
NNDM
$314M
| $523K | ﹤0.01% |
180,986
-33,109
| -15% | -$82K |
|
3242
Mesa Laboratories
MLAB
$551M
| $521K | ﹤0.01% |
4,057
+1,441
| +55% | +$220K |
|
3243
Invesco Global Water ETF
PIO
$271M
| $521K | ﹤0.01% |
14,565
+1,568
| +12% | +$54.9K |
|
3244
AMC Global Media
AMCX
$450M
| $521K | ﹤0.01% |
43,575
+16,398
| +60% | +$237K |
|
3245
Anika Therapeutics
ANIK
$215M
| $520K | ﹤0.01% |
20,016
-11,465
| -36% | -$307K |
|
3246
Prudential
PUK
$36.4B
| $520K | ﹤0.01% |
18,351
+6,270
| +52% | +$180K |
|
3247
Phreesia
PHR
$689M
| $516K | ﹤0.01% |
16,642
+15,255
| +1,100% | +$478K |
|
3248
iShares MSCI Europe Financials ETF
EUFN
$4B
| $514K | ﹤0.01% |
26,793
+247
| +0.9% | +$4.76K |
|
3249
Lyell Immunopharma
LYEL
$318M
| $514K | ﹤0.01% |
8,076
-12,760
| -61% | -$706K |
|
3250
Levi Strauss
LEVI
$9.49B
| $513K | ﹤0.01% |
35,584
-45,573
| -56% | -$658K |
|
Similar funds
Citigroup's Q2 2023 Portfolio in Review
As of Q2 2023, Citigroup held 5,906 positions worth $153B, up 6.9% from $143B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citigroup's Q2 2023 filing shows 463 new, 2,756 increased, 1,590 reduced and 354 closed positions. Its largest new stake was Vesta Real Estate: 3,353,619 shares worth $108M. The largest sale was iShares Russell 2000 ETF, an estimated $713M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citigroup's largest Q2 2023 buy was Vesta Real Estate: 3,353,619 shares worth $108M.
- Citigroup added most to Vanguard Morningstar Total Stock Market ETF in Q2 2023, an estimated $718M increase.
- Citigroup's biggest Q2 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $713M.
- Citigroup fully exited DCP Midstream, LP in Q2 2023, selling an estimated $198M.
- Citigroup's ten largest holdings make up 34% of its $153B portfolio in Q2 2023.
- Citigroup opened 463 new positions and closed 354 in Q2 2023.
- Citigroup's portfolio value rose 6.9% quarter-over-quarter to $153B.
Based on Citigroup's 13F filing for Q2 2023, filed 10 Aug 2023.